Beyond viral elimination: the emerging epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD)-viral hepatitis overlap.

Egypt's landmark success in eliminating HCV and controlling HBV proves that large-scale, coordinated public health strategies can yield transformative results. However, the rising burden of MASLD now threatens these achievements. Confronting this emerging epidemic with the same urgency, innovation, and scale will be critical to safeguarding the gains of the past decade and securing the future of global liver health.